[The clinical use of the preparation kordaron in different arrhythmias].
Cordaron (amiodaron, angoron, atlansil, cordinil, trangorax) is a drug produced by the French-Belgian firm "Labaz". Some pharmacological properties of cordaron and in particular its ability to increase the refractory period both of the atrioventricular junction and the abnormal pathway that hampers the circulation of excitation between the atria and ventricles influencing the mechanism of reverse excitation provide favourable conditions for elimination of arrhythmias. In a number of papers of the Soviet and foreign authors there are presented the results of cordaron treatment of patients with various cardiac rhythm disorders which indicate a fairly high antiarrhythmic effectiveness of the drug. Its lethal dose is practically absent. Side effects show up only during a prolonged therapy and disappear after the drug withdrawal.
A A
AA
Galstian
A G
AG
Zaraelian
D000638:Amiodarone / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D004341:Drug Evaluation; D006321:Heart / Q000187:drug effects; D006801:Humans
D000638:Amiodarone
Klinicheskoe primenenie preparata "Kordaron" pri razlichnykh aritmiiakh.